Add articles to your saved list and come back to them any time. A man who allegedly drove two teenagers around Melbourne while they used slingshots and marbles to shatter the windows of apartments ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

LifeArc will provide expertise in humanization of monoclonal antibodies (MAbs) to target key drivers of conditions identified by Cleveland Clinic, including cancer and complement-mediated diseases.

Y-mAbs Therapeutics is parting ways with its chief commercial officer and putting a new hire in charge of the cancer drug Danyelza. The biotech made the changes, which include “a small ...

Late this week, a quartet of companies—IGM Biosciences, Y-mAbs Therapeutics, Passage Bio and Shoreline Biosciences—each revealed plans to cut jobs as they rework their respective pipelines and ...

Platform can deliver a variety of payloads and could potentially be developed against multiple tumor targets, as well as for radiopharmaceutical purposes. Y-mAbs is currently evaluating its SADA PRIT ...

Y mAbs Therapeutics (YMAB) (ISIN: US9842411095)股票专题，提供今日Y mAbs Therapeutics(YMAB) (ISIN: US9842411095)股票最新股价查询，实时市场行情，走势图表，及Y mAbs Therapeutics(YMAB) (ISIN: ...

They can then make many copies of that antibody in the lab. These are known as monoclonal antibodies (mAbs or Moabs). Monoclonal antibodies are used to treat many diseases, including some types of ...